Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Multiple sclerosis

New consensus guidelines on vaccination in multiple sclerosis

Nature Reviews Neurology volume 19, pages 509–510 (2023)Cite this article

Subjects

The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and European Academy of Neurology (EAN) joint consensus statement on vaccination in people with multiple sclerosis provides highly relevant clinical guidance on immunization strategies in today’s era of effective immunotherapies. Nevertheless, several open questions remain to be addressed.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Otero-Romero, S. et al. ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: improving immunization strategies in the era of highly active immunotherapeutic drugs. Mult. Scler. https://doi.org/10.1177/13524585231168043 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Farez, M. F. et al. Practice guideline update summary: vaccine-preventable infections and immunization in multiple sclerosis: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 93, 584–594 (2019).

    Article  PubMed  Google Scholar 

  3. Winkelmann, A., Loebermann, M., Barnett, M., Hartung, H.-P. & Zettl, U. K. Vaccination and immunotherapies in neuroimmunological diseases. Nat. Rev. Neurol. 18, 289–306 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Kaufmann, S. H. E. in Vaccination — Basics, Effects, Risks 11–12 (C. H. Beck, 2021).

  5. Rommer, P. S. et al. Immunological aspects of approved MS therapeutics. Front. Immunol. 10, 1564 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Manouchehrinia, A., Tanasescu, R., Tench, C. R. & Constantinescu, C. S. Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios. J. Neurol. Neurosurg. Psychiatry 87, 324–331 (2016).

    Article  PubMed  Google Scholar 

  7. Apostolidis, S. A. et al. Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy. Nat. Med. 27, 1990–2001 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Silva, P. B. R. & Silva, G. D. Risk and characteristics of attacks occurring after vaccination in patients with neuromyelitis optica spectrum disorders: a systematic review and meta-analysis. Mult. Scler. Relat. Disord. 75, 104741 (2023).

    Article  CAS  PubMed  Google Scholar 

  9. Krienke, C. et al. A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis. Science 371, 145–153 (2021).

    Article  CAS  PubMed  Google Scholar 

  10. Löbermann, M. et al. [Multiple sclerosis and hepatitis B vaccination : What does the verdict of the European Court of Justice on liability after vaccination mean?]. Nervenarzt 89, 1172–1178 (2018).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Neuroimmunological Section, University of Rostock, Rostock, Germany

    Uwe K. Zettl

  2. Department of Neurology, Medical University of Vienna, Vienna, Austria

    Paulus S. Rommer

Authors
  1. Uwe K. Zettl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paulus S. Rommer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paulus S. Rommer.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zettl, U.K., Rommer, P.S. New consensus guidelines on vaccination in multiple sclerosis. Nat Rev Neurol 19, 509–510 (2023). https://doi.org/10.1038/s41582-023-00854-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41582-023-00854-7

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing